Prophylactic platelet transfusions: Should they be a treatment of the past?

Current Opinion in Hematology

Volumn 21, Issue 6, 2014, Pages 521-527

  Zeller, Michelle P ^a   Al Habsi, Khalid S ^a   Heddle, Nancy M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Hematologic malignancy; Platelets; Prophylactic transfusions

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; CANCER PROGNOSIS; DOSE RESPONSE; HEMATOLOGIC MALIGNANCY; HEMOSTASIS; HUMAN; OUTCOME ASSESSMENT; PETECHIA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; ADVERSE EFFECTS; PROCEDURES;

HUMANS; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOCYTOPENIA;

EID: 84927639918     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000087     Document Type: Review

References (19)

1. Higby DJ, Cohen E, Holland JF, Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion 1974; 14:440-446.
2. Murphy S, Litwin S, Herring LM, et al. Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982; 12:347-356.
3. Solomon J, Bofenkamp T, Fahey J, et al. Platelet prophylaxis in acute nonlymphoblastic leukemia. Lancet 1978; 1:267.
4. Sintnicolaas K, Velden K, Sizoo W, et al. Comparison of prophylactic and therapeutic single-donor platelet transfusions in patients with acute leukaemia. Br J Hematol 1982; 50:684.
5. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997; 337:1870-1875.
6. Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012; 5: CD004269.
7. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362:600-613.
8. Wandt H, Schaefer-Eckart K, Frank M, et al. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37:387-392.
9. Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelettransfusion strategy for hematologic cancers. N Engl J Med 2013; 368:1771-1780.
10. Wandt H, Schaefer-Eckart K, Wendelin K, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012; 380:1309-1316.
11. Stanworth SJ, Estcourt LJ, Llewelyn C A, et al. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. Transfusion 2014. [Epub ahead of print]
12. Slichter SJ. Eliminate prophylactic platelet transfusions? N Engl J Med 2013; 368:1837-1838.
13. Schiffer CA. Haematological cancer: prophylactic platelet transfusion is frequently not necessary. Nat Rev Clin Oncol Nature Publishing Group 2013; 10:431-432.
14. Heddle NM, Cook RJ. Composite outcomes in clinical trials: what are they and when should they be used? Transfusion 2011; 51:11-13.
15. Heddle NM, Arnold DM, Webert KE. Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion 2011; 51:430-434.
16. Heddle NM, Cook RJ, Webert KE, et al. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003; 43:742-752.
17. Estcourt LJ, Heddle N, Kaufman R, et al. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion 2013; 53:1531-1543.
18. Heddle NM, Wu C, Vassallo R, et al. Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges. Transfusion 2011; 51:2304-2310.
19. Webert KE, Arnold DM, Lui Y, et al. A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia. Transfusion 2012; 52:2466-2474; quiz 2465.